This AI-focused health stock is a buy that can rally nearly 50%, BTIG says
Analyst Mark Massaro initiated coverage on the stock with a buy rating.
You are not logged in so some information on this page has been withheld. To see more, please log in.
Mark Massaro
since
auto-detected in 34 stories
44 days ago
This AI-focused health stock is a buy that can rally nearly 50%, BTIG says
Analyst Mark Massaro initiated coverage on the stock with a buy rating.
page 1 of 1